GLP-1 Side Effects | What’s Normal and When to Call Your Doctor

Starting a GLP-1 medication can be an important step toward better weight management, blood sugar control, and metabolic health. But after the first dose, many patients have another question:

How do I know which GLP-1 side effects are normal and which ones mean I should call my doctor?

Nausea, diarrhea, constipation, vomiting, indigestion, abdominal discomfort, and changes in appetite are among the most common side effects associated with medications such as semaglutide and tirzepatide.

For many patients, digestive symptoms are manageable. However, severe or persistent vomiting, significant dehydration, severe abdominal pain, symptoms of gallbladder disease, or a serious allergic reaction should never be dismissed as simply part of the medication working.

At Crabapple Medical Center in Alpharetta, GA, medical weight management involves more than prescribing medication. Appropriate follow-up helps patients manage side effects, adjust treatment when necessary, and use GLP-1 based therapy as safely as possible.

What Are GLP-1 Medications?

GLP-1 receptor agonists are medications that mimic glucagon-like peptide-1, a hormone involved in blood sugar regulation, appetite, and digestion.

GLP-1 medications can help stimulate insulin release when glucose is elevated, reduce appetite, increase feelings of fullness, and slow stomach emptying. Some are approved for type 2 diabetes, some for chronic weight management, and certain medications have additional FDA-approved indications.

Semaglutide is a GLP-1 receptor agonist and is found in medications such as Wegovy and Ozempic.

Tirzepatide, found in Zepbound and Mounjaro, is technically a dual GIP and GLP-1 receptor agonist because it acts on both GIP and GLP-1 pathways. It is commonly included in discussions about GLP-1 based weight-loss treatment.

Because these medications affect appetite and gastrointestinal function, it makes sense that many of their most common side effects involve the digestive system.

What Are the Most Common GLP-1 Side Effects?

The exact side effects depend on which medication you take, your dose, your medical history, and how your body responds.

Common GLP-1 side effects can include:

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Abdominal discomfort or pain
• Indigestion
• Heartburn
• Bloating
• Belching
• Reduced appetite
• Fatigue
• Headache
• Injection-site reactions with injectable medications

Current FDA labeling for Wegovy lists nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, bloating, belching, gas, heartburn, and several other effects among its common adverse reactions. Zepbound commonly causes nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection-site reactions, fatigue, belching, hair loss, and heartburn.

Experiencing one of these symptoms does not automatically mean you need to stop treatment.

What matters is how severe the symptom is, how long it lasts, whether you can eat and drink normally, and whether it is getting better or worse.

Quick Guide: What's Common and What's Concerning?

The severity and context of symptoms matter. FDA labeling specifically advises patients to contact their healthcare provider when gastrointestinal symptoms are severe, persistent, or contribute to dehydration.

Why Does GLP-1 Medication Cause Nausea?

Nausea is one of the most frequently reported GLP-1 side effects.

One reason is that GLP-1 based medications affect gastrointestinal function and slow gastric emptying. Food may remain in the stomach longer, which can increase fullness and help reduce appetite but may also contribute to nausea, bloating, or digestive discomfort.

This is also why eating the same large portions you ate before beginning treatment may become uncomfortable.

Your body may now signal fullness sooner.

Rather than trying to eat through that sensation, recognizing your new fullness signals can make treatment easier to tolerate.

Is Nausea Normal on GLP-1 Medication?

Mild nausea can be a common treatment side effect.

The more important question is whether the nausea is manageable.

Nausea that is mild, allows you to continue drinking fluids, and does not significantly interfere with daily activities may be something your healthcare provider can help you manage while continuing treatment.

Nausea deserves more attention when it becomes severe, continues without improvement, prevents adequate food or fluid intake, or occurs with repeated vomiting or significant abdominal pain.

MedlinePlus specifically advises patients taking semaglutide or tirzepatide to tell their doctor when nausea, vomiting, diarrhea, constipation, or other listed side effects become severe or do not go away.

How Can You Reduce GLP-1 Nausea?

Eating differently can sometimes make treatment easier to tolerate.

Practical strategies commonly recommended for nausea include eating smaller meals, stopping when you begin to feel full, choosing bland foods when your stomach is unsettled, and limiting high-fat foods that may worsen nausea.

For example, instead of three large meals, smaller portions spread throughout the day may be easier to tolerate.

Eating slowly can also give your body more time to recognize fullness.

Do not force yourself to finish a meal simply because that was your normal serving size before starting medication.

If nausea remains significant despite these changes, speak with your healthcare provider rather than trying to manage increasingly severe symptoms on your own.

What About Vomiting?

Occasional vomiting can occur with GLP-1 based medications, but repeated vomiting deserves closer attention.

The concern is not only the vomiting itself.

Frequent vomiting can lead to dehydration. Fluid loss can then contribute to kidney problems, particularly when vomiting or diarrhea continues. Both current Wegovy and Zepbound safety information warn about dehydration-related kidney injury.

Contact your provider if vomiting continues, becomes frequent, or prevents you from keeping fluids down.

Seek more urgent medical attention if vomiting occurs with severe persistent abdominal pain, fainting, confusion, severe weakness, or other significant symptoms.

Is Diarrhea a Normal GLP-1 Side Effect?

Yes. Diarrhea is another commonly reported side effect.

Mild diarrhea that resolves and does not interfere significantly with hydration may be manageable.

Persistent diarrhea is different.

Because diarrhea causes fluid loss, prolonged symptoms increase the risk of dehydration. Current GLP-1 medication safety information advises patients to contact their healthcare provider when nausea, vomiting, or diarrhea does not go away.

Signs that you may not be maintaining adequate hydration can include significant thirst, dry mouth, dizziness, reduced urination, or unusual weakness.

If you cannot replace lost fluids, contact your healthcare provider promptly.

Does GLP-1 Medication Cause Constipation?

It can.

Constipation is common with both semaglutide and tirzepatide.

Changes in how quickly food moves through the digestive system, reduced food intake, lower fluid intake, and dietary changes may all contribute.

Mild constipation can often be discussed at a routine medication follow-up.

Constipation becomes more concerning if it is severe, continues for an extended period, causes increasing abdominal pain or swelling, is accompanied by repeated vomiting, or you are unable to pass stool or gas.

Do not assume that severe abdominal symptoms are simply normal constipation because you are taking a GLP-1 medication.

Can GLP-1 Medications Cause Heartburn and Burping?

Yes.

Indigestion, heartburn, belching, bloating, and gas can occur during treatment.

These symptoms may relate to changes in gastric emptying and how much food you can comfortably eat at one time. Wegovy and Zepbound both include several upper gastrointestinal symptoms among their commonly reported adverse reactions.

Smaller meals and avoiding foods that consistently trigger symptoms may help.

Persistent or severe reflux should be discussed with your provider, particularly if symptoms interfere with eating, sleeping, or your ability to continue treatment.

Why Side Effects Can Become More Noticeable After a Dose Increase

GLP-1 and GLP-1 based medications are generally started at lower doses and increased gradually.

This titration process is intentional.

Current Wegovy prescribing information states that its dose escalation schedule is designed to reduce gastrointestinal adverse reactions. Zepbound is similarly started at a lower dose and increased gradually according to tolerability and treatment response.

If you tolerated one dose well but develop significant nausea, vomiting, diarrhea, or other symptoms after increasing the dose, tell your healthcare provider.

It does not automatically mean the medication is wrong for you.

Your provider may need to assess whether the current dose is appropriate or whether a change in the treatment plan is needed.

Do not increase, decrease, skip, or alter your prescription dose without discussing it with your healthcare provider.

When Should You Call Your Doctor About GLP-1 Side Effects?

You should contact your healthcare provider when symptoms are more than mild or are interfering with your ability to eat, drink, function normally, or continue treatment.

Examples include persistent nausea, repeated vomiting, diarrhea that does not resolve, significant constipation, worsening abdominal discomfort, or digestive symptoms that are severe or do not go away.

Current Wegovy and Zepbound labeling specifically warns that severe gastrointestinal reactions can occur.

You should also call your provider if you develop symptoms suggestive of gallbladder problems, experience unexpected blood sugar changes, notice concerning vision changes if you have diabetes, or develop a new lump or swelling in your neck.

The safest approach is to contact your provider when a symptom feels meaningfully different from the mild digestive discomfort you were told to expect.

Severe Abdominal Pain Is Not a Side Effect to Ignore

One of the most important warning signs for patients taking GLP-1 based medication is severe, persistent abdominal pain.

Acute pancreatitis, or inflammation of the pancreas, has been reported with GLP-1 receptor agonists and dual GIP and GLP-1 medicines.

Pain associated with pancreatitis may be severe, may not go away, and can sometimes radiate into the back. Nausea or vomiting may also occur. Current safety guidance recommends urgent medical evaluation for this symptom pattern.

Do not assume severe abdominal pain is simply indigestion from your medication.

If you develop severe, persistent stomach pain, especially if the discomfort reaches your back or occurs with vomiting, seek urgent medical attention.

What Are Signs of Gallbladder Problems?

GLP-1 based medications are also associated with gallbladder problems, including gallstones and gallbladder inflammation.

Current FDA medication information advises patients to contact their healthcare provider for symptoms that may include:

• Pain in the upper abdomen
• Yellowing of the skin or eyes
• Fever
• Clay-colored stools

Not every episode of stomach discomfort is related to the gallbladder. However, significant upper abdominal pain combined with jaundice or fever deserves prompt medical evaluation.

Can GLP-1 Side Effects Cause Dehydration?

Yes.

The medication itself is not necessarily dehydrating you directly. The problem occurs when nausea, vomiting, or diarrhea causes excessive fluid loss or makes it difficult to drink enough.

Severe dehydration can affect kidney function.

Both current Wegovy and Zepbound prescribing information include warnings regarding acute kidney injury related to volume depletion.

Contact your provider if vomiting or diarrhea continues or if you cannot maintain adequate fluid intake.

Maintaining hydration is especially important while experiencing gastrointestinal side effects.

Can GLP-1 Medication Cause Low Blood Sugar?

GLP-1 medications do not carry the same hypoglycemia risk in every patient.

The risk becomes more important when certain GLP-1 based medications are used with insulin or medications that increase insulin secretion, such as sulfonylureas.

Both Wegovy and Zepbound labeling warn that combining treatment with insulin or an insulin secretagogue can increase the risk of hypoglycemia.

Possible symptoms of low blood sugar can include shakiness, sweating, dizziness, hunger, weakness, confusion, or a fast heartbeat.

Patients who use diabetes medications should discuss glucose monitoring and possible medication adjustments with their healthcare provider.

Severe hypoglycemia involving confusion, inability to safely treat yourself, seizure, or loss of consciousness requires immediate assistance.

What About Allergic Reactions?

Serious allergic reactions are uncommon but require immediate attention.

Semaglutide and tirzepatide labeling includes warnings for serious hypersensitivity reactions, including anaphylaxis and angioedema.

Seek emergency medical care if you develop signs such as swelling of your face, lips, tongue, or throat, difficulty breathing or swallowing, severe rash, or other symptoms suggesting a serious allergic reaction.

Do not wait for these symptoms to improve on their own.

Can GLP-1 Medications Affect the Thyroid?

Current Wegovy and Zepbound prescribing information carries a boxed warning concerning thyroid C-cell tumors.

In animal studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is not known whether these medications cause medullary thyroid carcinoma in humans. Both medications are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Contact your healthcare provider if you notice:

A new lump or swelling in your neck, persistent hoarseness, difficulty swallowing, or difficulty breathing.

This boxed warning does not mean everyone taking a GLP-1 medication will develop thyroid cancer. It means providers need to screen medical and family history carefully before treatment and patients should know the symptoms that require evaluation.

Can GLP-1 Medications Affect Your Eyes?

This issue is especially relevant for patients with type 2 diabetes.

Current Wegovy and Zepbound prescribing information includes precautions related to diabetic retinopathy complications or worsening in certain patients with pre-existing diabetic eye disease.

If you have diabetic retinopathy, tell your healthcare provider before starting treatment.

Report new or worsening vision problems promptly.

Routine diabetes care should also include appropriate eye examinations, particularly for patients already living with diabetic eye disease.

Should You Stop GLP-1 Medication Because of Side Effects?

Not automatically.

Mild gastrointestinal symptoms can sometimes be managed without stopping treatment.

On the other hand, severe or persistent symptoms should not simply be tolerated because you want to continue losing weight.

Your healthcare provider may need to evaluate your dose, hydration, nutrition, medications, underlying gastrointestinal conditions, and other factors.

For suspected pancreatitis, current prescribing information directs patients to stop the medication and contact a healthcare provider promptly.

For other side effects, the appropriate decision depends on the individual situation.

Do not make repeated dose adjustments on your own.

What Should You Eat When GLP-1 Side Effects Are Bothering You?

The goal is not to develop a complicated "GLP-1 diet."

Instead, pay attention to how your body responds.

If nausea is present, smaller meals may be easier to tolerate than large portions. Stop eating when you feel full and consider bland foods when your stomach is unsettled. High-fat foods may worsen nausea for some patients.

Hydration is also important, particularly if you have diarrhea or vomiting.

As symptoms improve, your overall nutrition still matters.

Because GLP-1 medications can significantly reduce appetite, it is possible to eat less food without necessarily eating better food. Your treatment plan should still prioritize adequate nutrition, protein, fiber, hydration, and other nutrients based on your individual medical needs.

Do Not Try to "Push Through" Severe Side Effects for Faster Weight Loss

More side effects do not mean the medication is working better.

Severe nausea is not a goal.

Repeated vomiting is not a sign of successful treatment.

Being unable to eat or drink adequately is not a healthy weight-loss strategy.

Medical weight management should improve health while keeping treatment tolerable and nutritionally appropriate.

If you feel that you need to endure severe symptoms simply to reach a certain dose or lose weight faster, talk with your healthcare provider.

The appropriate dose is not necessarily the highest dose. Current prescribing information emphasizes treatment response and tolerability when selecting or escalating doses.

Tell Your Medical Team Before Surgery or Sedation

GLP-1 based medications slow gastric emptying.

Current Wegovy and Zepbound prescribing information includes warnings about reports of pulmonary aspiration during general anesthesia or deep sedation in people receiving GLP-1 based therapy.

If you are scheduled for surgery, an endoscopy, dental sedation, or another procedure involving anesthesia or deep sedation, make sure the medical team knows that you use a GLP-1 or GLP-1 based medication.

Your surgical or anesthesia team should decide how to manage your medication before the procedure based on current clinical guidance and your individual circumstances.

Do not stop treatment on your own solely because a procedure is approaching unless your healthcare team instructs you to do so.

GLP-1 Medications and Pregnancy

Weight-loss medication is not intended for use during pregnancy.

Current Wegovy labeling advises discontinuing the medication when pregnancy is recognized when it is being used for weight or cardiovascular risk reduction. For patients planning pregnancy, semaglutide should generally be stopped at least two months before the planned pregnancy because it remains in the body for an extended period.

Current Zepbound labeling also advises discontinuing treatment when pregnancy is recognized. Tirzepatide can additionally affect the absorption of oral hormonal contraceptives because it delays gastric emptying. Current labeling advises certain patients using oral hormonal contraception to switch to a non-oral contraceptive method or add a barrier method for four weeks after starting tirzepatide and for four weeks following each dose increase.

Tell your healthcare provider if you are pregnant, planning pregnancy, or using hormonal contraception before beginning treatment.

Are Suicidal Thoughts a Proven GLP-1 Side Effect?

This topic has received considerable attention online, but the latest FDA information is important.

In April 2026, the FDA announced that a comprehensive review did not find an increased risk of suicidal thoughts or behavior associated with GLP-1 receptor agonists and requested removal of the related warning from prescribing information for weight-management GLP-1 medications that previously carried it.

The February 2026 Zepbound and Wegovy labeling reflects removal of this warning.

Regardless of medication, new or severe mental health symptoms deserve medical attention.

Be Careful With Unapproved or Improperly Compounded GLP-1 Products

Side-effect safety also depends on knowing what medication and dose you are actually receiving.

The FDA has raised concerns about unapproved GLP-1 products marketed for weight loss, including dosing errors, fraudulent labeling, inappropriate storage, and products whose quality, safety, and effectiveness have not been reviewed in the same manner as FDA-approved medications.

The agency has previously received reports of patients requiring medical attention or hospitalization following dosing errors involving compounded semaglutide. Reported problems included nausea, vomiting, abdominal pain, dehydration, pancreatitis, and gallstones.

Medical weight-loss treatment should involve a legitimate healthcare provider and an appropriate pharmacy rather than medication obtained from an unknown online source.

What Should You Track While Taking a GLP-1?

You do not need to become obsessed with every sensation after an injection.

A simple record can still be useful.

Consider keeping track of when you take your medication, your current dose, nausea or other gastrointestinal symptoms, bowel movements if constipation is a problem, significant vomiting or diarrhea, hydration, appetite changes, and anything unusual that occurs after a dose increase.

This information can make follow-up appointments more useful.

Instead of simply telling your provider, "I feel sick on the medication," you can explain when symptoms begin, how long they last, and whether they changed after your dose was increased.

That gives your healthcare team better information for deciding what to do next.

When to Call Your Doctor vs When to Seek Emergency Care

One of the easiest ways to think about GLP-1 side effects is to divide symptoms into three groups.

Usually Monitor and Discuss

Mild nausea, mild constipation, occasional diarrhea, burping, heartburn, bloating, reduced appetite, mild fatigue, or temporary digestive discomfort may be manageable.

Discuss these symptoms with your provider if they continue, interfere with eating, or become bothersome.

Contact Your Healthcare Provider Promptly

Call your provider when you have persistent vomiting or diarrhea, cannot maintain adequate hydration, experience severe or ongoing gastrointestinal symptoms, develop worsening constipation with significant abdominal discomfort, notice possible gallbladder symptoms, develop new vision changes, or notice a lump or persistent hoarseness in your neck.

Seek Urgent or Emergency Medical Care

Seek immediate medical attention for severe persistent abdominal pain that may radiate into your back, especially with nausea or vomiting, because this can be a sign of pancreatitis.

Emergency evaluation is also appropriate for difficulty breathing, swelling of the face, lips, tongue, or throat, loss of consciousness, or other symptoms of a severe allergic reaction or medical emergency.

When symptoms are severe, do not wait for a routine weight-management appointment.

Why Medical Supervision Matters With GLP-1 Treatment

Successful GLP-1 therapy involves more than getting a prescription and watching the number on the scale.

Your provider should know your medical history, current medications, diabetes treatment, kidney and gallbladder history, gastrointestinal conditions, pregnancy plans, family history, and other factors that could influence treatment safety.

Follow-up then allows your healthcare team to review your progress and determine whether the medication and dose remain appropriate.

Crabapple Medical Center's existing weight-management approach includes medical assessment and individualized treatment rather than using one strategy for every patient.

This becomes particularly important when side effects appear.

The goal is not simply to keep taking medication at any cost. The goal is to find a treatment approach that is effective, medically appropriate, and tolerable.

GLP-1 Weight Management at Crabapple Medical Center in Alpharetta, GA

At Crabapple Medical Center, medical weight management is personalized around your health history, metabolic needs, lifestyle, and treatment goals.

GLP-1 based medications may be appropriate for some patients, but treatment should include careful evaluation, realistic expectations, nutrition and lifestyle support, and ongoing medical monitoring.

Crabapple Medical Center also incorporates GLP-1 receptor agonists into appropriate diabetes treatment and provides individualized medication management, lifestyle counseling, and continued follow-up for chronic disease care.

If you are already taking semaglutide, tirzepatide, or another GLP-1 based medication and are struggling with side effects, do not simply stop treatment or change your dose without guidance.

Talk with your healthcare provider about what you are experiencing.

A medication plan can only work well when it is both effective and safe for you.

Know What Is Normal and Know When to Speak Up

The most common GLP-1 side effects involve the digestive system.

Mild nausea, constipation, diarrhea, indigestion, bloating, and appetite changes can occur during treatment.

But there is an important difference between something common and something you should simply tolerate.

Symptoms that are severe, persistent, cause dehydration, prevent you from eating or drinking, or include significant abdominal pain deserve medical attention.

Severe persistent abdominal pain, especially when it radiates toward the back, requires urgent evaluation because it may indicate pancreatitis. Serious allergic symptoms require emergency medical care.

GLP-1 Weight Management in Alpharetta, GA

Starting a GLP-1 or dealing with side effects? Our team helps you find the right approach and stay on track.

Personalized medical supervision can help you get the benefits of treatment without overlooking the signals your body is giving you.

Frequently Asked Questions